Why the study?
Recent stagnation or worsening trends in CVD risk factors, including LDL-c and obesity, might slow the decline in Japan's CVD burden.
What is the impact of national changes in cardiovascular disease risk factor distributions on Japan's cardiovascular disease burden from 2001 to 2019?
What is the impact of national changes in cardiovascular disease risk factor distributions on Japan's cardiovascular disease burden from 2001 to 2019?
Reductions in systolic blood pressure and smoking drove most of the decline in cardiovascular disease burden in Japan from 2001 to 2019, while rising BMI and poor lifestyle factors partially offset these benefits.
Rising BMI may offset Japan's CVD gains from SBP and smoking control; leaves open targeted prevention priorities.
Background Recent stagnation or worsening trends in cardiovascular disease (CVD) risk factors, including low-density lipoprotein cholesterol (LDL-c) and obesity, might slow the decline in Japan's CVD burden. We aimed to quantify the impact of national changes in CVD risk factor distributions on Japan's CVD burden from 2001 to 2019. Methods We conducted a microsimulation study with counterfactual analysis using IMPACT NCD-JPN , a validated model based on real-world data. It simulated a synthetic Japanese population (ages 30–99) from 2001 to 2019 using life-course data on seven CVD risk factors, estimating CVD incidence, mortality, and healthcare economics for synthetic individuals. The base-case reflected observed trends; counterfactual scenarios assumed 2001 levels persisted. Primary outcome was national CVD incidence (stroke and coronary heart disease). Findings From 2001 to 2019, systolic blood pressure (SBP) and smoking declined markedly (men/women) by 6·8/7·2 mmHg and 18·4/6·8%, respectively, while LDL-c, HbA1c, body mass index (BMI), physical activity (PA), and fruit/vegetable (FV) consumption showed smaller or adverse trends. Under the base-case and counterfactual scenarios, IMPACT NCD-JPN estimated CVD incidence and quantified the differences between the scenarios. The changes in the CVD risk factors prevented or postponed 840,000 (95% uncertainty interval: 540,000–1,300,000) national CVD cases, cumulative from 2001 to 2019. Individual contributions were: SBP 540,000; smoking 280,000; LDL-c 27,000; HbA1c 7900; BMI −15,000; PA −16,000; and FV consumption −11,000. Interpretation SBP and smoking reductions drove most CVD burden declines in Japan (2001–2019). Modest benefits came from LDL-c and HbA1c, while rising BMI, and low PA and FV intake partly offset these benefits. Funding JSPS KAKENHI JP22K17821, JP25K02863; the Ministry of Health, Labour and Welfare Comprehensive Research on Life-Style Related 22FA1015, 24FA1015.
No takes yet. Share an insight, caveat, or question.
Ogata et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: